What this is
The CRISPR Atlas is a free educational reference to gene editing. It covers the technologies, the diseases they are aimed at, the treatments built from them, the trials testing those treatments, the companies and scientists behind them, the genes involved, the research underneath, and the arguments about whether some of it should be done at all.
It is built as a database rather than a blog. Every concept — a technology, a disease, a gene, a trial, a company, a person, a paper — is a record with a stable address, and records are explicitly linked to each other. That is why a sickle cell page can show you the treatments, trials, companies, genes and scientists connected to it without anyone hand-writing those lists, and why the site can keep growing without turning into an archive nobody can navigate.
Who it is for
Several people at once, which is the hard part. A patient's parent trying to understand what a trial result means. A student who has never taken a biology class. An investor trying to tell a platform from a press release. A journalist on deadline. A researcher checking a date. The compromise we have settled on is this: every page opens with a plain-language answer that a bright middle-school student can follow, and then goes into technical detail below it. Nothing is dumbed down; the sequence is just reversed from how a textbook would do it.
The rules we hold ourselves to
- Evidence level on every claim. Approved treatment, clinical research, preclinical research, laboratory research, and future possibility are five different things, and conflating them is the single most common failure in coverage of this field. Every relevant record carries its level explicitly.
- Never imply an experimental therapy is proven. A drug in Phase III is not a treatment. A promising mouse study is not a cure. We would rather sound cautious than exciting.
- Real news only. Headlines come from named publishers and always link out. We do not rewrite, republish or generate news, and we would rather show an empty section than a fabricated one.
- Primary sources. Regulators, registries, and the peer-reviewed literature, cited on the page. Where we summarise a paper we link the original; we do not reproduce copyrighted articles.
- Contested credit stays contested. Attribution in gene editing is genuinely disputed, including in court. Where that is true, we say so instead of picking a side.
- No medical advice, ever. Not in an article, not in the AI assistant, not by implication.
How it is made
Records are compiled and written by the Atlas editorial team, working from the primary sources named on each page, and are maintained through an internal admin system rather than by editing code — which is what makes the last-updated dates meaningful. Portions of the content and the data compilation are produced with AI-assisted research; figures are indicative and may be out of date. Every page carries an author, a last-updated date, and its sources, so you can see exactly how old a claim is and where it came from.
What it is not
It is not a medical service, a trial-matching service, a patient registry, or an investment research product. It cannot tell you whether a treatment is right for you, and it will not try. If a decision about real medical care is involved, the right next step is a conversation with a qualified clinician — not a website.
Corrections
If something here is wrong, we want to fix it, and we would rather hear about it from you than leave it up. Send the page, the claim and ideally the source you think is right through the contact page. Substantive corrections are made to the record and change its last-updated date.